When Colleges Accept Golden Handcuffs from the Medical Cartel...

Rutgers has been captured

Since it’s $1 billion deal with RWJBarnabus, Rutgers has become something of a clinical trial factory.

And it was entirely by design.

Academic health care systems and public-private partnerships are all the rage. Here’s Rutgers Biomedical and Health Sciences Chancellor Brian Strom describing the benefits of this arrangement:

RWJ Barnabas has committed to a $1 billion investment over the next 20 years in facilities and services. Ostrowsky couldn’t say exactly where or how the bricks and mortar side of the deal will happen, but Rutgers Biomedical and Health Sciences Chancellor Brian Strom said the added capacity of Barnabas will have an impact on the bottom line by helping the new entity get a larger slice of grants and clinical studies.

“We can go to contract for research with pharma and NIH [National Institutes of Health] and other agencies, saying we have this huge population we can bring, a very diverse population, a major strength that New Jersey has to be able to bring to these clinical trials, [and] with that bring additional revenue,” noted Strom. (emphasis mine)

https://www.njspotlightnews.org/video/rutgers-rwj-barnabas-consummate-deal-for-large-academic-health-system/

And everything is going as planned.

Rutgers now boasts a new state-of-the-art facility, which has hosted COVID-19 vaccine clinical trials by Johnson & Johnson, Moderna and Pfizer, including pediatric vaccine clinical trials for children 6 months to 4 years. And it is now enrolling children for a clinical trial for a Lyme disease vaccine being developed by Pfizer and French vaccine manufacturer Valneva.

https://childrenshealthdefense.org/defender/rutgers-pfizer-lyme-disease-vaccine-trial/

If you’re wondering if universities like Rutgers are willing to bite the hand that feeds them, consider Rutgers’ efforts to drive COVID policy since that time:

Rutgers Doubles Down on “Obey To Play” COVID Policies Despite Science

According to his Linked-In profile, Rutgers COO and Executive Vice President Antonio Calcado was on the steering team that spearheaded the lucrative partnership with RWJ. In early 2020, he was selected to lead the Rutger’s COVID-19 Task Force and “led the COVID-19 response for the university and healthcare system throughout the pandemic.” According to his profile, he was also “instrumental in implementing the first university COVID vaccine mandate in the country.” 

Calcado has zero background in science, medicine or public health.

In an interview with Rutgers Magazine he acknowledged, “I am not an expert in any of the areas that the leaders are addressing. I don’t know any of these things, but what I do know is that we can’t let the perfect be the enemy of the good.”

This is the person who is still setting important precedents for public health policy.

Currently, Rutgers Biomedical and Health Sciences, the same school that is requiring all students and employees to “obtain a booster when eligible” is promoting a new, variant-specific “bivalent” booster on social media.  

You can see a thread of headlines demonstrating all the ways the university has worked to push vaccines and fight vaccine hesitancy and “misinformation” here.

Rutgers is in the Vaccine Business

Do we really want to trust the minds of the future to these institutions?